FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Orders are growing as contract-manufacturing agreements with customers in Korea and abroad follow one another.

  • Follow-on order for clinical material from a Korean biosimilar customer. Source
  • First CDMO agreement with a Japanese global pharmaceutical company. Source

Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Prestige Biologics

A biologics contract development and manufacturing organisation producing everything from clinical material to commercial drug substance.

Biologics CDMO

Service

Contract manufacturing of clinical material and commercial drug substance for pharmaceutical companies in Korea and abroad.

Announced

Signed its first CDMO agreement with a Japanese global pharmaceutical company.

Announced

Won a follow-on order to make clinical material for a Korean biosimilar customer.

Official role guide

Prestige Biologics careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 프레스티지바이오로직스, 일본 빅파마와 CDMO 계약 ↗뉴스핌 · Published 2026-05-15 · Sources checked 2026-11-15 · Original unavailable
  2. 프레스티지바이오로직스, 바이오시밀러 CDMO 수주 ↗뉴스핌 · Published 2026-06-10 · Sources checked 2026-11-15 · Original unavailable